Determining the potential benefits, costs, and value of a potential capstone project to the organization requires a thoughtful comparison of the benefits and costs, an

Determining the potential benefits, costs, and value of a potential capstone project to the organization requires a thoughtful comparison of the benefits and costs, an analysis of project features as value considerations, and the development of anticipated measurable outcomes. Complete a critical analysis of a potential doctoral capstone project and make final recommendations, based on the project’s benefits, costs, and value to the organization. The assignment requirements, outlined below, correspond to the scoring guide criteria, so be sure to address each main point. Read the performance-level descriptions for each criterion to see how your work will be assessed. In addition, note the additional requirements for document format, length, and supporting evidence. 2. Improve multi-level factors that contribute to this organizational challenge- Application of the evidence in an organizational level would result to changes mitigating system barriers such as financial costs and resources limitations. Also, community engagement from the individual level would increase participation and ownership of the research. Meanwhile, the individual level evidence reduces individual barriers like population support reducing agreements to enrollment. Interpersonal level evidence addresses barriers related to biasness, communication, and understanding of the trials. 3. Remove culture biases- improve application of effective research strategies which are culture and language sensitive Considering the multilevel framework of interventions, the organization is likely to facilitate improvements through organizational and individual levels to mitigate the negative impact of the challenge. This can be associated with resources, finance, assistance, support, awareness, community engagement, and positive attitudes towards the trials. The organization would stipulate its contribution of resources and finances since they are challenging factors in the population to reduce under-representation and lack of participation in trials. Assistance, support, awareness, and community engagement would be influenced through application of the resources towards effective organization-community relationships. The interventions specifically apply to the population characteristics through exposure to unique barriers. The barriers such as biasness and under-representation in clinical research resonate with the population. The interventions articulated consider equity and cultural sensitivity of the population. In addition, the population experiences a lot of disparities when assessing quality health care. The interventions ensure that their participation in the trials would lead to quality cancer care through reduced generalization of findings and treatments. The intervention is supported by all the articles articulating its quality and applicability in reducing the negative impacts of the organizational challenge. Additionally, the articles provide substantial evidence which effectively supports the specific intervention. This is because of its effectiveness and applicability. Considering the level of the intervention, it is appropriate as it directly deals with the organization, the community, and individual population members. To impact changes on inclusion in trials, the community, organization, and members ought to be involved. This is facilitated through education, awareness, support, and assistance. Community and organizational support are significant in enabling the inclusion of minorities in oncology clinical trials. Reference George, S., Duran, N. & Norris, K. (2014). A systematic review of barriers and facilitators to minority research participation among African Americans, Latinos, Asian Americans, and Pacific Islanders. 104(2). doi:10.2105/AJPH.2013. 301706) Hamel, L., Penner, L., Albrecht, T., Heath, E., Gwede, C. & Eggly, S. (2016). Barriers to clinical enrollment in racial and ethnic minority patients with cancer. 23(4), 327-337. Nipp, R., Hing, K. & Paskett, E. (2019). Overcoming barriers to clinical trial enrollment. 10.1200/EDBK_ 243729

Do you need us to help you on this or any other assignment?

Make an Order Now